Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 160Leukemia, Myeloid, Acute 123Leukemia, Myelomonocytic, Chronic 65Leukemia 35Myeloproliferative Disorders 23Primary Myelofibrosis 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Hematologic Neoplasms 10Myelodysplastic-Myeloproliferative Diseases 9Recurrence 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Neoplasms 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Polycythemia Vera 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Hematologic Diseases 4Anemia, Refractory 4Thrombocythemia, Essential 3Prostatic Neoplasms 3Neoplasm, Residual 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

fludarabine 3Melphalan 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Cyclophosphamide 2Busulfan 2Bone Marrow Transplantation 2venetoclax 1spartalizumab 1sabatolimab 1ruxolitinib 1lintuzumab 1Sertraline 1Sampling Studies 1Lenalidomide 1Decitabine 1CPI-0610 1Biopsy 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Preleukemia × Azacitidine × Myeloid × Clear all
NCT03066648 2025-05-18

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

Novartis

Phase 1 Completed
241 enrolled
MyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Preleukemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡